NLRP3 and COVID-19: The outcomes of this study will provide scientific-based evidence to support the use of C. petasites extract and its bioactive flavonoids as therapeutic strategies for COVID-19-related chronic inflammation by targeting the NLRP3 inflammasome pathway.